IP Library Granted Patent US 9,714,946
Granted Patent B2
US 9,714,946 · App. 14/774,958 · Granted Jul 25, 2017

Bromodomain binding reagents and uses thereof

Inventors: James E. Bradner (Weston, MA); Jun Qi (Sharon, MA)
Assignee: Dana-Farber Cancer Institute, Inc.
G01N33/58C07D495/14C07D519/00G01N33/5008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,714,946
App. No.
14/774,958
Granted
Jul 25, 2017
Kind
B2
Abstract

The present invention provides compounds of the Formula (I) and (II), and salts thereof, wherein L 1 , L 2 , A, B, Z, and R O are as defined herein. The present invention also provides synthetic intermediates, methods of preparation and use, and kits comprising such compounds. Such compounds, when bound to a label or probe (B), may be useful in various assays for identifying bromodomain binding agents, for example, specific for the BET-family of bromodomains.

Claims (24)

1. A compound of Formula (I):

or salt thereof;

wherein:

L 1 is a bond or a linking group selected from the group consisting of substituted or unsubstituted alkylene; substituted or unsubstituted alkenylene; substituted or unsubstituted alkynylene; substituted or unsubstituted heteroalkylene; substituted or unsubstituted heteroalkenylene; substituted or unsubstituted heteroalkynylene; substituted or unsubstituted heterocyclylene; substituted or unsubstituted carbocyclylene; substituted or unsubstituted arylene; substituted or unsubstituted heteroarylene; and combinations thereof;

L 2 is a linking group selected from the group consisting of substituted or unsubstituted alkylene; substituted or unsubstituted alkenylene; substituted or unsubstituted alkynylene; substituted or unsubstituted heteroalkylene; substituted or unsubstituted heteroalkenylene; substituted or unsubstituted heteroalkynylene; substituted or unsubstituted heterocyclylene; substituted or unsubstituted carbocyclylene; substituted or unsubstituted arylene; substituted or unsubstituted heteroarylene; and combinations thereof;

A is a bond, —NR W1 —, —NR W1 —NR W1 —, —S—, —O—, —S—S—

wherein is a single or double bond, W is —O—, —S—, or —NR W1 —, R W1 is hydrogen, substituted or unsubstituted alkyl, or an amino protecting group; and Q is —NR W1 —, —NR W1 —NR W1 —, —S—, —O—; and B is a detectable label.

2. The compound of claim 1 , wherein L 1 is a linker group comprising a combination of one or more groups of the formula:

wherein R L is hydrogen or substituted or unsubstituted alkyl, n is 0 or an integer between 1 to 10, inclusive.

3. The compound of claim 1 , wherein L 2 is a linker group comprising a combination of one or more groups of the formula:

wherein R L is hydrogen or substituted or unsubstituted alkyl, m is 0 or an integer between 1 to 10, inclusive.

4. The compound of claim 1 , wherein A is

5. The compound of claim 1 , wherein A is

6. The compound of claim 1 , wherein A is —NR W1 —, —NR W1 —NR W1 —, —S—, —O—, or —S—S—.

7. The compound of claim 1 , wherein A is:

8. The compound of claim 1 , wherein A is:

9. The compound of claim 1 , wherein A is:

10. The compound of claim 1 , wherein A is:

11. The compound of claim 1 , wherein the compound is of formula:

or a salt thereof.

12. The compound of claim 1 , wherein the compound is of formula:

or a salt thereof.

13. The compound of claim 1 , wherein the compound is of Formula:

or a salt thereof.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 16, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039696/0845 →
CONFIRMATORY LICENSE Recorded Aug 16, 2016
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039701/0621 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2015
From: BRADNER, JAMES E.; QI, JUN
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 036763/0098 →
Continuity (2)
Provisional Application 61781472 · Mar 14, 2013
Related Publication 20160033519A1 · Feb 4, 2016